Zenas BioPharma, Inc. (ZBIO) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 10M | 5M | 0 | 0 | 0 | 0 | 50M |
| Revenue Growth % | -100% | -100% | - | - | - | - | -100% | - | - | - | - |
| Cost of Goods Sold | 6K | 0 | 5M | 43.03M | 0 | 0 | 33.53M | 33.81M | 22.64M | 20.42M | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -6K | 0 | -5M | -43.03M | 10M | 5M | -33.53M | -33.81M | -22.64M | -20.42M | 50M |
| Gross Margin % | - | - | - | - | 100% | 100% | - | - | - | - | 100% |
| Gross Profit Growth % | -100.06% | -100% | 85.09% | -27.27% | 144.16% | 124.49% | -167.06% | - | - | - | - |
| Operating Expenses | 77.34M | 237.98M | 47.58M | 12.14M | 47.33M | 60.62M | 7.45M | 5.89M | 4.93M | 4.36M | 14.38M |
| OpEx % of Revenue | - | - | - | - | 473.3% | 1212.46% | - | - | - | - | 28.75% |
| Selling, General & Admin | 16.91M | 15.59M | 13.18M | 12.14M | 12.41M | 11.47M | 7.45M | 5.89M | 4.93M | 4.36M | 5.02M |
| SG&A % of Revenue | - | - | - | - | 124.15% | 229.32% | - | - | - | - | 10.05% |
| Research & Development | 60.44M | 55.72M | 34.4M | 43.03M | 34.91M | 49.16M | 33.53M | 33.81M | 22.64M | 20.42M | 9.35M |
| R&D % of Revenue | - | - | - | - | 349.15% | 983.14% | - | - | - | - | 18.7% |
| Other Operating Expenses | 0 | 1000K | 0 | -1000K | 0 | 0 | -1000K | -1000K | -1000K | -1000K | 0 |
| Operating Income | -77.35M | -237.98M | -52.58M | -55.16M | -37.33M | -55.62M | -40.98M | -39.7M | -27.58M | -24.78M | 35.62M |
| Operating Margin % | - | - | - | - | -373.3% | -1112.46% | - | - | - | - | 71.25% |
| Operating Income Growth % | -107.21% | -327.85% | -28.29% | -38.94% | -35.36% | -124.48% | -215.05% | - | - | - | - |
| EBITDA | -77.34M | -237.97M | -52.57M | -55.15M | -37.31M | -55.59M | -40.95M | -39.67M | -27.55M | -24.75M | 35.65M |
| EBITDA Margin % | - | - | - | - | -373.07% | -1111.8% | - | - | - | - | 71.3% |
| EBITDA Growth % | -107.32% | -328.09% | -28.38% | -39.03% | -35.44% | -124.62% | -214.86% | - | - | - | - |
| D&A (Non-Cash Add-back) | 6K | 10K | 11K | 12K | 23K | 33K | 36K | 35K | 33K | 30K | 26K |
| EBIT | -77.35M | -230.42M | -51.5M | -55.16M | -33.78M | -55.62M | -40.98M | -39.7M | -27.58M | -24.78M | 35.62M |
| Net Interest Income | -3.61M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 3.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 6.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -3.64M | -2.35M | 1.08M | 2.96M | 3.55M | 3.45M | 2.38M | 1.73M | -222K | 493K | -16K |
| Pretax Income | -80.99M | -240.34M | -51.5M | -52.2M | -33.78M | -52.17M | -38.61M | -37.98M | -27.8M | -24.29M | 35.61M |
| Pretax Margin % | - | - | - | - | -337.78% | -1043.5% | - | - | - | - | 71.22% |
| Income Tax | 0 | 106K | 0 | 20K | -205K | 429K | 0 | 0 | 0 | 301K | 0 |
| Effective Tax Rate % | 0% | -0.04% | 0% | -0.04% | 0.61% | -0.82% | 0% | 0% | 0% | -1.24% | 0% |
| Net Income | -80.99M | -240.44M | -51.5M | -52.22M | -33.57M | -52.6M | -38.61M | -37.98M | -27.8M | -24.59M | 35.61M |
| Net Margin % | - | - | - | - | -335.73% | -1052.08% | - | - | - | - | 71.22% |
| Net Income Growth % | -141.23% | -357.08% | -33.4% | -37.51% | -20.77% | -113.95% | -208.42% | - | - | - | - |
| Net Income (Continuing) | -80.99M | -240.44M | -51.5M | -52.22M | -33.57M | -52.6M | -38.61M | -37.98M | -27.8M | -24.59M | 35.61M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.46 | -5.17 | -1.22 | -1.25 | -0.80 | -1.26 | -0.92 | -0.99 | -0.73 | -0.64 | 0.21 |
| EPS Growth % | -82.5% | -310.32% | -32.61% | -26.26% | -9.59% | -96.88% | -538.1% | - | - | - | - |
| EPS (Basic) | -1.46 | -5.17 | -1.22 | -1.25 | -0.80 | -1.26 | -0.92 | -0.99 | -0.73 | -0.64 | 0.21 |
| Diluted Shares Outstanding | 55.62M | 46.49M | 42.16M | 41.87M | 41.8M | 41.79M | 41.78M | 38.32M | 38.32M | 38.32M | 41.78M |
| Basic Shares Outstanding | 55.62M | 46.49M | 42.16M | 41.87M | 41.8M | 41.79M | 41.78M | 38.32M | 38.32M | 38.32M | 41.78M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - |